Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer.
AUSTIN, Texas, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM” or the “Company”), a clinical-stage biopharmaceutical company focused...
AUSTIN, Texas, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM” or the “Company”), a clinical-stage biopharmaceutical company focused...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.1072 | 0.1072 | 0.1072 | 0 | 0 | CS |
4 | -0.2728 | -71.7894736842 | 0.38 | 0.399 | 0.1 | 1195650 | 0.19315631 | CS |
12 | -0.6328 | -85.5135135135 | 0.74 | 1.13 | 0.1 | 12046171 | 0.54675527 | CS |
26 | -1.2428 | -92.0592592593 | 1.35 | 1.59 | 0.1 | 7547995 | 0.63854482 | CS |
52 | -3.4828 | -97.0139275766 | 3.59 | 4.12 | 0.1 | 3846109 | 0.64661435 | CS |
156 | -57.1928 | -99.8129144852 | 57.3 | 57.9 | 0.1 | 1423943 | 1.97246726 | CS |
260 | -207.1928 | -99.948287506 | 207.3 | 286.8435 | 0.1 | 988126 | 23.93194652 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales